Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Carisma Therapeutics is developing a unique, differentiated immuno-oncology (IO) treatment for solid tumors based on chimeric antigen receptor macrophages (CAR-M). Current IO treatments have ...

"The fact that viral RNA alone seems to be able to trigger memory in macrophages lays the foundation of this memory being antigen independent," Lercher says. "They're recognizing a pattern that is ...

Researchers from the University of Minnesota are developing a cell therapy that would combat Alzheimer’s disease using ...

Chimeric antigen receptor (CAR) T cell therapies have made remarkable strides in treating ... Clinical samples provided evidence for macrophage-mediated CD47-dependent phagocytosis of CAR-T cells, ...